Interestingly, autoantibodies against aberrantly glycosylated MUC1 have been associated with ovarian cancer, and they have the potential to serve as non-invasive biomarkers for earlier diagnosis of OC [41]. The gene discussed is MUC1; the disease is ovarian cancer.